Jaggi, R

Rothschild, S; Amrein, Michael; Riether, Carsten; Gautschi, O; Schuster, N; Li, Q; Savic, S; Schneider, M; Biaggi, C; Bubendorf, L; Brutsche, M; Zippelius, A; Zander, T; Betticher, D; Früh, M; Stahel, R; Cathomas, R; Rauch, Daniel; Pless, M; Ochsenbein, Adrian; ... (October 2017). CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09). Journal of thoracic oncology, 12(11S2), S1864-S1865. Elsevier

Girardin, D; Ballabio, N; Imboden, S; Pfaltz, K; Tapia, C; Jaggi, R; Altermatt, HJ; Aebi, S; Mueller, MD; Günthert, A (2013). Diskrepanz der klinisch-pathologischen "intrinsischen" Subtypen (IHC-Klassifikation, St-Gallen Konzensus 2011) zwischen Primärtumore und Lokalrezidive verglichen mit Diskrepanz zwischen Primärtumore und asynchrone Zweittumore beim Mammakarzinom. In: Jahreskongress SGGG, Lugano 2013. Jahreskongress SGGG, Lugano 2013

Rothschild, S I; Tschan, M P; Federzoni, E A; Jaggi, R; Fey, M F; Gugger, M; Gautschi, O (2012). MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. Oncogene, 31(38), pp. 4221-32. Basingstoke, UK: Nature Publishing Group 10.1038/onc.2011.578

Moor, A E; Guevara, C; Altermatt, H J; Warth, R; Jaggi, R; Aebi, S (2011). PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. Pathobiology, 78(3), pp. 140-8. Basel: Karger 10.1159/000323809

Baltzer, A; Svanborg, C; Jaggi, R (2004). Apoptotic cell death in the lactating mammary gland is enhanced by a folding variant of alpha-lactalbumin. Cellular and molecular life sciences, 61(10), pp. 1221-8. Basel: Birkhäuser-Verlag 10.1007/s00018-004-4046-7